X. Jaïs

M. Humbert, X. Jaïs, L. Savale, 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era

M. Humbert, V. Cottin, X. Jaïs, 2010, Circulation.

HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era

M. Humbert, X. Jaïs, L. Savale, 2010, AIDS.

Pulmonary veno-occlusive disease

M. Humbert, X. Jaïs, G. Simonneau, 2009, European Respiratory Journal.

Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease

M. Humbert, E. Fadel, X. Jaïs, 2009, European Respiratory Journal.

Review: Therapeutic advances in pulmonary arterial hypertension

M. Humbert, X. Jaïs, G. Simonneau, 2008, Therapeutic advances in respiratory disease.

Pulmonary Veno-Occlusive Disease: Clinical, Functional, Radiologic, and Hemodynamic Characteristics and Outcome of 24 Cases Confirmed by Histology

M. Humbert, X. Jaïs, G. Simonneau, 2008, Medicine.

Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension.

M. Humbert, X. Jaïs, G. Simonneau, 2006, European heart journal.

Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension.

M. Humbert, X. Jaïs, G. Simonneau, 2006, Chest.

Treatment of pulmonary arterial hypertension.

M. Humbert, X. Jaïs, G. Simonneau, 2004, The New England journal of medicine.

Severe Pulmonary Hypertension during Pregnancy: Mode of Delivery and Anesthetic Management of 15 Consecutive Cases

D. Benhamou, R. Frydman, M. Humbert, 2005, Anesthesiology.

Pulmonary arterial hypertension

M. Humbert, X. Jaïs, L. Savale, 2004, Breathe.

[Pulmonary arterial hypertension].

M. Humbert, X. Jaïs, B. Girerd, 2005, Revue des maladies respiratoires.

Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension

M. Humbert, X. Jaïs, L. Savale, 2009, European Respiratory Journal.

Pregnancy outcomes in pulmonary arterial hypertension in the modern management era

M. Humbert, P. Macdonald, J. Barberà, 2012, European Respiratory Journal.

Treatment of pulmonary arterial hypertension with targeted therapies

M. Humbert, X. Jaïs, L. Savale, 2011, Nature Reviews Cardiology.

Tyrosine Kinase Inhibitor–Induced Pulmonary Arterial Hypertension

M. Humbert, E. Jutant, X. Jaïs, 2018 .

Deterioration of pulmonary hypertension and pleural effusion with bosutinib following dasatinib lung toxicity

M. Humbert, X. Jaïs, L. Savale, 2016, European Respiratory Journal.

Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension.

M. Humbert, E. Fadel, L. Mouthon, 2012, Arthritis and rheumatism.

Endothelin receptor antagonists for the treatment of pulmonary arterial hypertension

M. Humbert, X. Jaïs, L. Savale, 2011, Expert opinion on pharmacotherapy.

Pulmonary Hypertension in Patients with Common Variable Immunodeficiency.

M. Humbert, P. De Groote, X. Jaïs, 2021, Journal of clinical immunology.

BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension

M. Humbert, E. Fadel, X. Jaïs, 2016, European Respiratory Journal.

Résultats tardifs de la commissurotomie mitrale percutanée à 20 ans Création et validation d ’ un score de risque prédisant les résultats fonctionnels à long terme à partir d ’ une série de 912 patients

M. Humbert, G. Zalcman, M. Macro, 2012 .

Hypertension artérielle pulmonaire postembolique tumorale

M. Humbert, X. Jaïs, G. Simonneau, 2007 .

Pulmonary Hypertension Complicating Fibrosing Mediastinitis

M. Humbert, D. Amar, E. Fadel, 2015, Medicine.

Pulmonary complications of Bcr-Abl tyrosine kinase inhibitors

M. Humbert, X. Jaïs, L. Savale, 2020, European Respiratory Journal.

Pulmonary hypertension in lymphangioleiomyomatosis: characteristics in 20 patients

M. Humbert, S. Harari, V. Cottin, 2012, European Respiratory Journal.

Chronic thromboembolic pulmonary hypertension.

M. Humbert, E. Fadel, X. Jaïs, 2015, Presse medicale.

EBUS-TBNA in the differential diagnosis of pulmonary artery sarcoma and thromboembolism

M. Humbert, X. Jaïs, G. Simonneau, 2012, European Respiratory Journal.

Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature

M. Humbert, E. Fadel, X. Jaïs, 2014, European Respiratory Journal.

Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry

J. Barberà, A. Torbicki, R. Speich, 2016, Circulation.

Mitomycin-Induced Pulmonary Veno-Occlusive DiseaseCLINICAL PERSPECTIVE

M. Humbert, V. Cottin, X. Jaïs, 2015 .

Association Between BMI and Obesity With Survival in Pulmonary Arterial Hypertension

M. Humbert, X. Jaïs, L. Savale, 2018, Chest.

Pulmonary veno-occlusive disease: recent progress and current challenges.

M. Humbert, X. Jaïs, L. Savale, 2010, Respiratory medicine.

Goal-oriented therapy in pulmonary veno-occlusive disease: a word of caution

M. Humbert, X. Jaïs, G. Simonneau, 2009, European Respiratory Journal.

Computed Tomography Findings Of Pulmonary Veno-Occlusive Disease In Scleroderma Patients Presenting With Precapillary Pulmonary Hypertension

M. Humbert, E. Fadel, L. Mouthon, 2012, ATS 2012.

Impact of High-Priority Allocation on Lung and Heart-Lung Transplantation for Pulmonary Hypertension.

M. Humbert, E. Fadel, X. Jaïs, 2017, The Annals of thoracic surgery.

Outcome of adults with Eisenmenger syndrome treated with drugs specific to pulmonary arterial hypertension: A French multicentre study.

M. Humbert, E. Fadel, L. Iserin, 2017, Archives of cardiovascular diseases.

Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study.

Z. Jing, H. Ghofrani, M. Madani, 2017, The Lancet. Respiratory medicine.

Right heart failure

M. Humbert, D. Amar, X. Jaïs, 2016 .

Serum and pulmonary uric acid in pulmonary arterial hypertension

M. Humbert, E. Fadel, V. Cottin, 2021, European Respiratory Journal.

Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective survey

M. Humbert, J. Barberà, X. Jaïs, 2012, European Respiratory Journal.

Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Results From an International Prospective Registry

J. Barberà, A. Torbicki, R. Speich, 2011, Circulation.

The association between resting and mild-to-moderate exercise pulmonary artery pressure

M. Humbert, D. Chemla, X. Jaïs, 2011, European Respiratory Journal.

Recent Advances in Pulmonary Hypertension

M. Humbert, X. Jaïs, G. Simonneau, 2014 .

Loss of Vascular Distensibility During Exercise Is an Early Hemodynamic Marker of Pulmonary Vascular Disease.

M. Humbert, D. Chemla, D. Celermajer, 2016, Chest.

RV Fractional Area Change and TAPSE as Predictors of Severe Right Ventricular Dysfunction in Pulmonary Hypertension: A CMR Study

M. Humbert, C. Rochitte, D. Chemla, 2018, Lung.

Lung capillary blood volume and membrane diffusion in precapillary pulmonary hypertension.

M. Humbert, D. Amar, X. Jaïs, 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Clinical and biological features in PIEZO1-hereditary xerocytosis and Gardos channelopathy: a retrospective series of 126 patients

C. Bénéteau, E. Deconinck, L. Garçon, 2019, Haematologica.

A roadmap for management of chronic thromboembolic pulmonary hypertension

M. Humbert, E. Fadel, X. Jaïs, 2019, European Respiratory Journal.

French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension

M. Humbert, E. Fadel, X. Jaïs, 2019, European Respiratory Journal.

Predictors of survival in patients with not-operated chronic thromboembolic pulmonary hypertension.

M. Humbert, E. Fadel, X. Jaïs, 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

The potential for macitentan, a new dual endothelin receptor antagonist, in the treatment of pulmonary arterial hypertension

M. Humbert, E. Jutant, X. Jaïs, 2014, Therapeutic advances in respiratory disease.

Long‐term outcome in liver transplantation candidates with portopulmonary hypertension

M. Humbert, D. Samuel, F. Durand, 2017, Hepatology.

Pulmonary veno-occlusive disease: the bête noire of pulmonary hypertension in connective tissue diseases?

M. Humbert, L. Mouthon, X. Jaïs, 2011, Presse medicale.

Efficacy, safety and pharmacokinetics of bosentan in portopulmonary hypertension

M. Humbert, X. Jaïs, L. Savale, 2012, European Respiratory Journal.

Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study

M. Humbert, X. Jaïs, L. Savale, 2017, European Respiratory Journal.

Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial.

A. Torbicki, H. Ghofrani, X. Jaïs, 2008, Journal of the American College of Cardiology.

[Pulmonary arterial hypertension].

M. Humbert, X. Jaïs, L. Savale, 2008, La Revue du praticien.

M. Humbert, K. Stenmark, X. Jaïs, 2015 .

Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension

A. Torbicki, R. Speich, M. Gómez-Sánchez, 2016 .

Characterization of pulmonary arterial hypertension patients walking more than 450 m in 6 min at diagnosis.

M. Humbert, X. Jaïs, L. Savale, 2010, Chest.

Medical Therapies for Chronic Thromboembolic Pulmonary Hypertension

M. Humbert, X. Jaïs, M. Hoeper, 2012 .

Medical therapies for chronic thromboembolic pulmonary hypertension: an evolving treatment paradigm.

M. Humbert, X. Jaïs, M. Hoeper, 2006, Proceedings of the American Thoracic Society.

Resting pulmonary artery pressure of 21–24 mmHg predicts abnormal exercise haemodynamics

M. Humbert, D. Chemla, D. Celermajer, 2016, European Respiratory Journal.

Gas Exchange and Ventilatory Efficiency During Exercise in Pulmonary Vascular Diseases

M. Humbert, X. Jaïs, L. Savale, 2020, Archivos de Bronconeumología (English Edition).

Gas Exchange and Ventilatory Efficiency During Exercise in Pulmonary Vascular Diseases.

M. Humbert, X. Jaïs, L. Savale, 2020, Archivos de bronconeumologia.

Dead-space ventilation is linked to exercise capacity and survival in distal chronic thromboembolic pulmonary hypertension.

M. Humbert, X. Jaïs, L. Savale, 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Phenotype and outcome of pulmonary arterial hypertension patients carrying a TBX4 mutation

M. Humbert, M. Remy-Jardin, V. Cottin, 2020, European Respiratory Journal.

Characteristics and long-term outcomes of pulmonary veno-occlusive disease induced by Mitomycin-C.

M. Humbert, V. Cottin, X. Jaïs, 2020, Chest.

Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive disease

M. Humbert, E. Fadel, X. Jaïs, 2015, European Respiratory Journal.

Ventilation/perfusion lung scan in pulmonary veno-occlusive disease

M. Humbert, X. Jaïs, B. Girerd, 2011, European Respiratory Journal.

Pulmonary arterial hypertension masquerading as severe refractory asthma

M. Humbert, X. Jaïs, G. Simonneau, 2008, European Respiratory Journal.

POEMS syndrome-related pulmonary hypertension is steroid-responsive.

M. Humbert, X. Jaïs, M. Chauveheid, 2007, Respiratory Medicine.

Risk categories from European guidelines applied to the French Pulmonary Hypertension (PH) registry

M. Humbert, V. Cottin, X. Jaïs, 2017 .

Pharmacovigilance in a rare disease: example of the VIGIAPATH program in pulmonary arterial hypertension

M. Humbert, X. Jaïs, L. Savale, 2018, International Journal of Clinical Pharmacy.

Chronic thromboembolic pulmonary hypertension and totally implantable central venous access systems

M. Humbert, E. Fadel, E. Jutant, 2020, European Respiratory Journal.

Impact Of Pulmonary Arterial Hypertension Specific Therapy On Portopulmonary Hypertension

M. Humbert, X. Jaïs, L. Savale, 2010, ATS 2010.

Association between Rheumatoid Arthritis and Pulmonary Hypertension: Data from the French Pulmonary Hypertension Registry

M. Humbert, V. Cottin, X. Jaïs, 2018, Respiration.

[Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis].

M. Humbert, X. Jaïs, G. Simonneau, 2010, Presse medicale.

Pulmonary hypertension associated with benfluorex exposure

M. Humbert, N. Lamblin, V. Cottin, 2012, European Respiratory Journal.

Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?

M. Humbert, X. Jaïs, L. Savale, 2020, American journal of respiratory and critical care medicine.

Klippel-Trenaunay syndrome as a rare cause of chronic thromboemboembolic pulmonary hypertension.

M. Humbert, E. Fadel, X. Jaïs, 2019, Respiratory medicine and research.

[Surgical treatment of chronic thromboembolic pulmonary hypertension].

M. Humbert, E. Fadel, X. Jaïs, 2014, Presse medicale.

Diagnostic et prise en charge de l’hypertension pulmonaire postembolique : le rôle du pneumologue

X. Jaïs, G. Simonneau, C. Leroyer, 2008 .

Left ventricular ejection time in acute heart failure complicating precapillary pulmonary hypertension.

M. Humbert, D. Chemla, X. Jaïs, 2013, Chest.

Evidence for the use of combination targeted therapeutic approaches for the management of pulmonary arterial hypertension.

M. Humbert, X. Jaïs, L. Savale, 2010, Respiratory medicine.

Splenectomy and chronic thromboembolic pulmonary hypertension

M. Humbert, P. Dartevelle, E. Fadel, 2005, Thorax.

Current management approaches to portopulmonary hypertension

M. Humbert, X. Jaïs, L. Savale, 2011, International journal of clinical practice. Supplement.

Risk stratification in patients with pulmonary arterial hypertension at the time of listing for lung transplantation.

M. Humbert, E. Fadel, X. Jaïs, 2022, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Extracorporeal Life Support After Pulmonary Endarterectomy as a Bridge to Recovery or Transplantation: Lessons From 31 Consecutive Patients.

P. Dartevelle, E. Fadel, X. Jaïs, 2016, The Annals of thoracic surgery.

Relation between left ventricular ejection time and pulmonary hemodynamics in pulmonary hypertension.

M. Humbert, D. Chemla, X. Jaïs, 2015, International journal of cardiology.

Accuracy of transpulmonary thermodilution cardiac output measurement (PiCCO) in patients with right heart failure (RHF) due to precapillary pulmonary hypertension (PH)

M. Humbert, X. Jaïs, L. Savale, 2013 .

Pulmonary arterial hypertension in patients treated with interferon

M. Humbert, X. Jaïs, L. Savale, 2014, European Respiratory Journal.

Factors predicting outcome after pulmonary endarterectomy

M. Humbert, E. Fadel, X. Jaïs, 2018, PloS one.

Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study.

M. Humbert, E. Fadel, P. De Groote, 2022, The Lancet. Respiratory medicine.

Mediastinal fibrosis mimicking proximal chronic thromboembolic disease.

M. Humbert, X. Jaïs, L. Savale, 2012, Circulation.

[Pulmonary arterial hypertension due to tumor emboli].

M. Humbert, X. Jaïs, G. Simonneau, 2007, Revue des maladies respiratoires.

Comparing cardiac magnetic resonance imaging in group 1 and group 4 pulmonary hypertension

M. Humbert, D. Chemla, X. Jaïs, 2011 .

Idiopathic pulmonary hypertension: what did we learn from genes?

M. Humbert, X. Jaïs, G. Simonneau, 2005, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[Genetics of pulmonary arterial hypertension: recent data and practical applications].

M. Humbert, X. Jaïs, G. Simonneau, 2005, Revue des maladies respiratoires.

Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

E. Vicaut, M. Dougados, M. Humbert, 2021, The Lancet Respiratory Medicine.

Screening for pulmonary arterial hypertension in adults carrying a BMPR2 mutation

M. Humbert, D. Chemla, X. Jaïs, 2020, European Respiratory Journal.

Direct oral anticoagulants: Still too early for prime time after pulmonary endarteriectomy?

X. Jaïs, L. Bertoletti, X. Delavenne, 2020, Journal of thrombosis and haemostasis : JTH.

Chronic blood exchange transfusions in the management of pre-capillary pulmonary hypertension complicating sickle cell disease

M. Humbert, X. Jaïs, L. Savale, 2018, European Respiratory Journal.

Direct-Acting Antiviral Medications for Hepatitis C Virus Infection and Pulmonary Arterial Hypertension.

M. Humbert, D. Samuel, X. Jaïs, 2016, Chest.

Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension

M. Humbert, V. Cottin, X. Jaïs, 2017, European Respiratory Journal.

From the authors:

M. Humbert, X. Jaïs, G. Simonneau, 2011, European Respiratory Journal.

Pulmonary hypertension associated with busulfan

M. Humbert, X. Jaïs, L. Savale, 2021, Pulmonary circulation.

Reversible pulmonary hypertension associated with multivisceral Whipple's disease

M. Humbert, E. Jutant, X. Jaïs, 2020, European Respiratory Journal.

Diagnostic concordance of different criteria for exercise pulmonary hypertension in subjects with normal resting pulmonary artery pressure

M. Humbert, D. Chemla, X. Jaïs, 2016, European Respiratory Journal.

Reply to Jin et al. and to Sun et al.

M. Humbert, X. Jaïs, L. Savale, 2021, American journal of respiratory and critical care medicine.

Chronic thromboembolic pulmonary hypertension complicating long-term cyproterone acetate therapy

M. Humbert, X. Jaïs, L. Bertoletti, 2014, European Respiratory Review.

Risks and outcomes of gastrointestinal endoscopy with anaesthesia in patients with pulmonary hypertension.

D. Benhamou, M. Humbert, X. Jaïs, 2020, British journal of anaesthesia.

Upfront Triple Combination Therapy Of I.V. Epoprostenol With Oral Bosentan And Sildenafil In Idiopathic And Heritable Pulmonary Arterial Hypertension

M. Humbert, X. Jaïs, L. Savale, 2011, ATS 2011.

Association between Leflunomide and Pulmonary Hypertension.

M. Humbert, N. Lamblin, X. Jaïs, 2021, Annals of the American Thoracic Society.

Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation.

D. Tregouet, M. Humbert, V. Drouin‐Garraud, 2010, American journal of respiratory and critical care medicine.

Portopulmonary hypertension: survival and prognostic factors.

M. Humbert, X. Jaïs, L. Savale, 2008, American journal of respiratory and critical care medicine.

P16 Treatment of VTE during pregnancy with a once-daily regimen of LMWH

X. Jaïs, G. Simonneau, F. Parent, 2009 .

Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension.

M. Humbert, X. Jaïs, L. Savale, 2010, European heart journal.

Noncardiothoracic nonobstetric surgery in mild-to-moderate pulmonary hypertension

M. Humbert, X. Jaïs, G. Simonneau, 2009, European Respiratory Journal.

External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry

M. Humbert, P. De Groote, V. Cottin, 2021, European Respiratory Journal.

Association Between Initial Treatment Strategy and Long-term Survival in Pulmonary Arterial Hypertension.

M. Humbert, P. De Groote, V. Cottin, 2021, American journal of respiratory and critical care medicine.

[Tunnelled central venous line-associated infections in patients with pulmonary arterial hypertension treated with intravenous prostacyclin].

M. Humbert, X. Jaïs, L. Savale, 2016, Presse medicale.

Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension

M. Humbert, Z. Jing, X. Jaïs, 2010, European Respiratory Journal.

Response to Letter Regarding Article, "Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension".

M. Humbert, X. Jaïs, G. Simonneau, 2015, Circulation.

Pulmonary hypertension in pregnancy

M. Humbert, X. Jaïs, L. Price, 2011 .

Occult alveolar haemorrhage in pulmonary veno-occlusive disease

M. Humbert, X. Jaïs, G. Simonneau, 2006, European Respiratory Journal.

COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort Study

P. De Groote, V. Cottin, E. Jutant, 2022, American journal of respiratory and critical care medicine.

A rare case of sarcoidosis-associated pulmonary hypertension in a patient exposed to silica

M. Humbert, X. Jaïs, L. Savale, 2016, European Respiratory Review.

Frequency and predictors for chronic thromboembolic pulmonary hypertension after a first unprovoked pulmonary embolism: Results from PADIS studies

S. Laporte, X. Jaïs, L. Savale, 2021, Journal of thrombosis and haemostasis : JTH.

Screening for pulmonary arterial hypertension in systemic sclerosis

M. Humbert, X. Jaïs, L. Savale, 2019, European Respiratory Review.

Pulmonary arterial hypertension

M. Humbert, X. Jaïs, B. Girerd, 2013, Orphanet Journal of Rare Diseases.

An emerging phenotype of pulmonary arterial hypertension patients carrying SOX17 variants

M. Humbert, E. Fadel, X. Jaïs, 2022, European Respiratory Journal.

Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension

M. Humbert, X. Jaïs, G. Simonneau, 2014, Circulation.

[Pulmonary veno-occlusive disease].

M. Humbert, X. Jaïs, B. Girerd, 2018, Revue des maladies respiratoires.

Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study.

M. Humbert, D. Amar, E. Fadel, 2017, The Lancet. Respiratory medicine.

Implementing the ESC/ERS pulmonary hypertension guidelines: real-life cases from a national referral centre

M. Humbert, X. Jaïs, L. Savale, 2009, European Respiratory Review.

Pulmonary Langerhans cell histiocytosis-associated pulmonary hypertension: clinical characteristics and impact of pulmonary arterial hypertension therapies.

M. Humbert, X. Jaïs, G. Simonneau, 2012, Chest.

Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial

E. Vicaut, M. Dougados, M. Humbert, 2021, The Lancet Rheumatology.

Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension

M. Humbert, P. De Groote, V. Cottin, 2017, European Respiratory Journal.

Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension

M. Humbert, X. Jaïs, G. Simonneau, 2005, Circulation.

Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation

M. Humbert, E. Jutant, X. Jaïs, 2020, European Respiratory Journal.

Intensity and quality of exertional dyspnoea in patients with stable pulmonary hypertension

M. Humbert, C. Morélot-Panzini, T. Similowski, 2019, European Respiratory Journal.

Inspiratory muscle function, dynamic hyperinflation and exertional dyspnoea in pulmonary arterial hypertension

M. Humbert, T. Similowski, X. Jaïs, 2015, European Respiratory Journal.

Respiratory symptoms and radiological findings in post-acute COVID-19 syndrome

M. Humbert, E. Jutant, X. Jaïs, 2021, ERJ Open Research.

Functional respiratory complaints among COVID-19 survivors: a prospective cohort study

M. Humbert, E. Corruble, T. Gille, 2023, ERJ Open Research.

[Treatment of pulmonary arterial hypertension].

Xavier Jaïs, David Montani, Marc Humbert, 2014, Presse medicale.

Targeted therapies in pulmonary arterial hypertension.

M. Humbert, X. Jaïs, B. Girerd, 2014, Pharmacology & therapeutics.

High occurrence of hypoxemic sleep respiratory disorders in precapillary pulmonary hypertension and mechanisms.

M. Humbert, X. Jaïs, P. Escourrou, 2013, Chest.

Highlights from the International Chronic Thromboembolic Pulmonary Hypertension Congress 2021

E. Fadel, M. Madani, X. Jaïs, 2023, European Respiratory Review.

Lung Ventilation/Perfusion Scintigraphy for the Screening of Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Which Criteria to Use?

M. Humbert, X. Jaïs, L. Savale, 2022, Frontiers in Medicine.

[Pulmonary arterial hypertension associated with common diseases: connective-tissue diseases, HIV infection and portal hypertension].

M. Humbert, X. Jaïs, G. Simonneau, 2008, La Revue du praticien.

Outcomes of patients with decreased arterial oxyhaemoglobin saturation on pulmonary arterial hypertension drugs

M. Humbert, X. Jaïs, L. Savale, 2021, European Respiratory Journal.

Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis

M. Humbert, V. Cottin, X. Jaïs, 2018, PloS one.

FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion.

Xavier Jaïs, Maurice Beghetti, Yves Dulac, 2016, International journal of cardiology.

Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension

M. Humbert, X. Jaïs, L. Bertoletti, 2009, European Respiratory Journal.

Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension

M. Humbert, X. Jaïs, L. Savale, 2009, Advances in therapy.

Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary veno-occlusive disease.

M. Humbert, E. Fadel, X. Jaïs, 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Initial dual oral combination therapy in pulmonary arterial hypertension

M. Humbert, P. De Groote, V. Cottin, 2016, European Respiratory Journal.

Criteria for diagnosis of exercise pulmonary hypertension

M. Humbert, D. Chemla, X. Jaïs, 2015, European Respiratory Journal.

Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases

M. Humbert, X. Jaïs, G. Simonneau, 2008, European Respiratory Journal.

, Hypertension Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial

M. Humbert, X. Jaïs, G. Simonneau, 2005 .

Phenotype and outcome of PAH patients carrying a TBX4 mutation.

M. Humbert, V. Cottin, X. Jaïs, 2020, The European respiratory journal.

Clinical Pharmacology of Endothelin Receptor Antagonists Used in the Treatment of Pulmonary Arterial Hypertension

M. Humbert, X. Jaïs, L. Savale, 2015, American Journal of Cardiovascular Drugs.

Efficacy and safety of tadalafil in portopulmonary hypertension

M. Humbert, X. Jaïs, L. Savale, 2018, Pulmonary hypertension.

Sequential combination therapy with parenteral prostacyclin in BMPR2 mutations carriers

M. Humbert, X. Jaïs, L. Savale, 2021, Pulmonary circulation.

Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Models.

M. Humbert, V. Cottin, X. Jaïs, 2015, Circulation.

Late Breaking Abstract - Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension: results from the randomised controlled RACE study

M. Humbert, E. Fadel, V. Cottin, 2019, Pulmonary hypertension.

313 French pulmonary arterial hypertension registry in children: 2-year follow-up data

P. Acar, X. Jaïs, C. Dauphin, 2010 .

Chronic thromboembolic pulmonary hypertension complicating long-term cyproterone acetate therapy

M. Humbert, X. Jaïs, L. Bertoletti, 2014, European Respiratory Review.

Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial Hypertension

M. Humbert, E. Fadel, P. De Groote, 2023, Circulation.

Out-of-Proportion Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction

M. Humbert, X. Jaïs, G. Simonneau, 2012, Respiration.

Are indexed values better for defining exercise pulmonary hypertension?

M. Humbert, D. Chemla, X. Jaïs, 2017, European Respiratory Journal.

Outcomes of cirrhotic patients with pre-capillary pulmonary hypertension and pulmonary vascular resistance between 2 and 3 Wood Units

M. Humbert, X. Jaïs, L. Savale, 2022, European Respiratory Journal.

Clinical and Hemodynamic Correlates of Pulmonary Arterial Stiffness in Incident, Untreated Patients With Idiopathic Pulmonary Arterial Hypertension

M. Humbert, D. Chemla, X. Jaïs, 2018, Chest.

Preoperative C-reactive protein predicts early postoperative outcomes after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension.

M. Humbert, E. Fadel, X. Jaïs, 2020, The Journal of thoracic and cardiovascular surgery.

Clinical relevance and prognostic value of renal Doppler in acute decompensated precapillary pulmonary hypertension.

M. Humbert, E. Fadel, X. Jaïs, 2023, European heart journal. Cardiovascular Imaging.

Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission

M. Humbert, X. Jaïs, L. Savale, 2021, European Respiratory Journal.

Mechanisms of exertional dyspnoea in pulmonary veno-occlusive disease with EIF2AK4 mutations

M. Humbert, T. Similowski, X. Jaïs, 2014, European Respiratory Journal.

Preoperative C-Reactive Protein Predicts Early Postoperative Outcomes after Pulmonary Endarterectomy in Patients with Chronic Thromboembolic Pulmonary Hypertension

M. Humbert, E. Fadel, X. Jaïs, 2019, The Journal of Heart and Lung Transplantation.

Usefulness of Cardiovascular Magnetic Resonance Indices to Rule In or Rule Out Precapillary Pulmonary Hypertension.

M. Humbert, C. Rochitte, D. Chemla, 2015, The Canadian journal of cardiology.

Cytokines as prognostic biomarkers in pulmonary arterial hypertension

M. Humbert, P. De Groote, X. Jaïs, 2022, European Respiratory Journal.

Six-Years Experience With High Priority Allocation Program for Lung and Heart-Lung Transplantation in Pulmonary Hypertension

M. Humbert, E. Fadel, X. Jaïs, 2015 .

The efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension: a 1-year follow-up study

M. Humbert, X. Jaïs, G. Simonneau, 2006, European Respiratory Journal.

Treatment of Pulmonary Arterial Hypertension

M. Humbert, X. Jaïs, G. Simonneau, 2004 .

[Treatment of pulmonary arterial hypertension].

M. Humbert, X. Jaïs, L. Savale, 2014, Presse medicale.

Pulmonary arterial hypertension in patients treated with interferon

M. Humbert, X. Jaïs, L. Savale, 2014, European Respiratory Journal.

Pulmonary Arterial Hypertension in Patients Treated by Dasatinib

M. Humbert, G. Zalcman, M. Macro, 2012, Circulation.

Involvement of the pulmonary micro-vasculature in chronic thromboembolic pulmonary hypertension (CTEPH)

M. Humbert, E. Fadel, X. Jaïs, 2012 .

Chronic thromboembolic pulmonary hypertension.

M. Humbert, P. Dartevelle, A. Chapelier, 2004, The European respiratory journal.

Updated Hemodynamic Definition and Classification of Pulmonary Hypertension

M. Humbert, X. Jaïs, D. Montani, 2023, Seminars in Respiratory and Critical Care Medicine.

Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension

M. Humbert, X. Jaïs, G. Simonneau, 2005, Circulation.

Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension

X. Jaïs, G. Simonneau, D. Montani, 2014 .

Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension

X. Jaïs, G. Simonneau, D. Montani, 2014 .

Recent Advances in Pulmonary Hypertension

M. Humbert, X. Jaïs, G. Simonneau, 2014 .

Pulmonary Arterial Hypertension in Patients Treated by Dasatinib

M. Humbert, G. Zalcman, M. Macro, 2012, Circulation.

Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension

M. Humbert, P. De Groote, V. Cottin, 2017, European Respiratory Journal.

Evaluation of a collaborative care program for pulmonary hypertension patients: a multicenter randomized trial

M. Humbert, V. Viaud, M. Roustit, 2020, International Journal of Clinical Pharmacy.

Updated Hemodynamic Definition and Classification of Pulmonary Hypertension

M. Humbert, X. Jaïs, D. Montani, 2023, Seminars in Respiratory and Critical Care Medicine.

Hemoptysis in Pulmonary Arterial Hypertension (PAH): A Life-Threatening Complication.

M. Humbert, X. Jaïs, L. Savale, 2009, ATS 2009.

IMPACT OF INITIATION OF BALLOON PULMONARY ANGIOPLASTY PROGRAM ON REFERRAL OF PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION TO SURGERY

M. Humbert, E. Fadel, X. Jaïs, 2018 .

Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era

M. Humbert, V. Cottin, X. Jaïs, 2010, Circulation.

Correcting For Age And Sex Unmasks Decreased Right Ventricular Ejection Fraction In Pulmonary Hypertension

M. Humbert, D. Chemla, X. Jaïs, 2011, ATS 2011.

[Management of right ventricular failure in pulmonary vascular diseases].

X. Jaïs, L. Savale, D. Montani, 2020, Revue des maladies respiratoires.

Current management approaches to portopulmonary hypertension

X. Jaïs, L. Savale, D. O’Callaghan, 2011, International journal of clinical practice. Supplement.

Outcomes and risk assessment in pulmonary veno-occlusive disease

X. Jaïs, L. Savale, M. Jevnikar, 2024, ERJ Open Research.

Phenotype and outcome of pulmonary arterial hypertension patients carrying a TBX4 mutation

M. Humbert, V. Cottin, X. Jaïs, 2020, European Respiratory Journal.

Pharmacological management of connective tissue disease-associated pulmonary arterial hypertension

X. Jaïs, L. Savale, M. Jevnikar, 2023, Expert Opinion on Pharmacotherapy.

Portopulmonary hypertension: survival and prognostic factors.

M. Humbert, X. Jaïs, L. Savale, 2008, American journal of respiratory and critical care medicine.

Evidence and unresolved questions in pulmonary hypertension: Insights from the 5th French Pulmonary Hypertension Network Meeting.

X. Jaïs, L. Savale, O. Sitbon, 2024, Respiratory medicine and research.

Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry

J. Barberà, A. Torbicki, R. Speich, 2016, Circulation.